Page 271 - Eshre Final Programme 2015

P-655 Assessment and validation of a next generation sequencing-based protocol for detection of chromosomal abnormalities in human preimplantation embryos
L. Ribustello1, S. Tormasi1, K. Bauckman1, P. Colls1, S. Munne2, M. Konstantinidis3
1Reprogenetics, aCGH Team, Livingston New Jersey, U.S.A. 2Reprogenetics, CEO, Livingston New Jersey, U.S.A. 3Reprogenetics, Research, Livingston New Jersey, U.S.A.
P-656 Development of a rapid low-pass whole genome sequencing technique for the diagnosis of microdelection and microduplication in human embryos prior to implantation
T. Feng1, K. Tan2, B. Xiong3, K. Yang1, G. Lin2
1Peking Jabrehoo Med Tech Co. Ltd, Research & development, Beijing, China
2Central South University, Institute of Reproduction and Stem Cell Engineering, Changsha, China 3Reproductive and Genetic Hospital of CITIC-Xiangya, Genetic center, Changsha, China
P-657 Human leukocyte antigen (HLA) matching of preimplantation embryos using a polymerase chain reaction (PCR) based methodology and Karyomapping.
M. Konstantinidis1, R. Prates1, S. Jaroudi2, N. Goodall1, K. Milligan1, D. Goldberg-Strassler3, R. Cabey3, S. Munne2, D. Wells4
1Reprogenetics, Molecular Department, Livingston New Jersey, U.S.A. 2Reprogenetics, Research and Development, Livingston New Jersey, U.S.A. 3Reprogenetics, Genetic Counseling, Livingston New Jersey, U.S.A. 4Reprogenetics UK, Research and Development, Oxford, United Kingdom
P-658 Low responders older than 37 have comparable success rates to normo/high-responders of same age using a novel Embryo-banking strategy including PGS at blastocyst stage
B. Ramos1, M. Fernández1, E. Rocafort1, L. Medrano-López1, M. Guijarro1, A. Leza1, N. Szlärb2, S. Rogel2, J. Aizpurua2
1IVFspain, Embryology, Alicante, Spain 2IVFspain, Gynecology, Alicante, Spain
P-659 IVF outcomes for patients that elect to undergo Preimplantation Genetic Screening (PGS)
E.E. Fischer1, C.R. Givens2, J. Conaghan1
1Pacific Fertility Center, Lab, San Francisco CA, U.S.A. 2Pacific Fertility Center, Clinical, San Francisco CA, U.S.A.
P-660 Clinical experience using single nucleotide polymorphism (SNP) arrays for preimplantation genetic diagnosis (PGD) of chromosomal translocations
J. Sarasa1, K. Wheeler1, L. Lansdowne1, A. Raberi2, D. Babariya2, D. Wells2
1Reprogenetics UK, Institute of Reproductive Sciences, Oxford, United Kingdom
2Nuffield Department of Obstetrics and Gynaecology, University of Oxford / Reprogenetics UK, Oxford, United Kingdom
FINAL PROGRAMME I LISBON, PORTUGAL – 14 TO 17 JUNE 2015 271
POSTERS